The Fundamental Case for and Against Exelixis, Inc. (EXEL)

Exelixis, Inc. (NASDAQ:EXEL) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 7.39B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Exelixis, Inc. (NASDAQ:EXEL) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For EXEL, the company currently has 149.36 million of cash on the books. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 609.77 million in total assets, balanced by 371.06 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Exelixis, Inc. (EXEL) saw 36.73 million in free cash flow last quarter, representing a quarterly net change in cash of 14.15 million. Perhaps most importantly where cash movements are concerned, the company saw about 37.87 million in net operating cash flow.

Exelixis, Inc. (NASDAQ:EXEL) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 152.61 million in total revenues. That represents a quarterly year/year change in revenues of 1.45 in sequential terms, the EXEL saw sales decline by 0.54.

But what about the bottom line? After all, that’s what really matters in the end. Exelixis, Inc. (EXEL) is intriguing when broken down to its core data. The cost of selling goods last quarter was 4.66 million, yielding a gross basic income of 147.95 million. For shareholders, given the total diluted outstanding shares of 312.94 million, this means overall earnings per share of 0.26. Note, this compares with a consensus analyst forecast of 0.12 in earnings per share for its next fiscal quarterly report.

Is Exelixis, Inc. (NASDAQ:EXEL) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 1.4 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 38.40. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Exelixis, Inc..

Previous ArticleNext Article

Related Post

Drilling Down Into the Books for Cooper Tire &... Cooper Tire & Rubber Company (NYSE:CTB) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market val...
The Fundamental Case for and Against Infosys Limit... Infosys Limited (NYSE:INFY) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now tradi...
HCP, Inc. (NYSE:HCP): Detailed technical analysis ... HCP, Inc. (NYSE:HCP) fell by -0.57% on final trading day of July 2017 from $31.83 to $31.65 and has now fallen 4 consecutive sessions. The price has f...
Synergy Pharmaceuticals Inc. (SGYP): More In-Depth... It's worth it to have a look at Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) as there may be a chasm between the bulls and the bears as far as recent tr...
The Long Case For Wells Fargo & Company (WFC) Wells Fargo & Company (NYSE:WFC) is an interesting stock at present. Now trading with a market value of 265.71B, the company has a mix of catalyst...